Rockwell Medical, Inc.
RMTI
$0.94
-$0.01-0.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -346.28% | 56.01% | 96.86% | 94.31% | 86.69% |
| Total Depreciation and Amortization | 0.09% | -0.91% | 18.86% | 50.97% | 108.68% |
| Total Amortization of Deferred Charges | -69.69% | -69.88% | -76.09% | -61.52% | 216.53% |
| Total Other Non-Cash Items | 22.07% | 12.96% | 4.22% | -3.15% | -22.29% |
| Change in Net Operating Assets | -48.82% | 84.31% | 51.62% | 78.92% | 64.48% |
| Cash from Operations | -163.30% | 173.87% | 139.10% | 144.65% | 134.74% |
| Capital Expenditure | -29.14% | -67.98% | -236.33% | -255.99% | -102.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -108.57% | -193.40% | -191.33% | -140.16% | -117.21% |
| Cash from Investing | -87.85% | 2.34% | 44.28% | -59.80% | -37.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 55.20% | 61.93% | 64.20% | 65.74% | 64.06% |
| Issuance of Common Stock | 54.91% | -57.91% | -37.61% | -31.49% | -45.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -142.43% | -49,900.00% | -41,200.00% | -32,480.00% | -2,081.40% |
| Cash from Financing | 112.45% | -74.40% | -47.44% | -35.21% | -37.48% |
| Foreign Exchange rate Adjustments | 66.67% | 33.33% | -400.00% | -25.00% | 40.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -72.22% | -78.68% | 211.69% | 696.87% | 187.70% |